| TECHNOLOGY |
There may be overcapacity in general, but we are continuing to build new assets. "Companies with standard technology may be suffering because they have no particular way of enticing business. You need something that's differentiating." IN LARGE-SCALE chiral separations, for example, Co. is aiming to develop a superior alternative to current methods with a technique based on molecular recognition. Customer response has been encouraging, with separations comparable with that achieved by simulated moving beds or crystallization. Plans are under way to have an operational plant for clinical-trial volumes within a year, he adds.
|